Latest filing published 02 Feb 2017 for Puma Biotechnology, INC., €70k.
Filing timeline
BuySaleInsider track record
Robert Charnas: trading record in brief
Robert Charnas is a declared insider of Puma Biotechnology, Inc., with filings sourced from SEC (Form 4). Between 14 October 2016 and 1 February 2017, the trades on record add up to 5 filings.
No open-market purchase appears, only 4 sales worth €230k. Other entries cover 1 share grant. 2017 to date brings no purchases and 4 sales.
The record was last updated on 2 February 2017 with an open-market sale (€70k) in Puma Biotechnology, Inc. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert Charnas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,239 shares@ US$33.2430.4% of flowCOMMON STOCKSEC:0001209191-17-007216:0
- 1,000 shares@ US$31.8012.8% of flowCOMMON STOCKSEC:0001209191-17-007221:0
- 2,008 shares@ US$31.8525.7% of flowCOMMON STOCKSEC:0001209191-17-007221:1
- 2,293 shares@ US$33.2431.1% of flowCOMMON STOCKSEC:0001209191-17-005350:0
- 31,500 shares0COMMON STOCKSEC:0001209191-16-145979:0
5 of 5 declarations
